Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Century Therapeutics (IPSC) Return on Equity (2022 - 2025)

Century Therapeutics (IPSC) has disclosed Return on Equity for 4 consecutive years, with 0.13% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Equity rose 49.0% to 0.13% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.13%, a 49.0% increase, with the full-year FY2024 number at 0.73%, down 17.0% from a year prior.
  • Return on Equity was 0.13% for Q3 2025 at Century Therapeutics, down from 0.1% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.1% in Q2 2025 to a low of 0.74% in Q1 2024.
  • A 4-year average of 0.47% and a median of 0.52% in 2023 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: tumbled -31bps in 2024, then skyrocketed 63bps in 2025.
  • Century Therapeutics' Return on Equity stood at 0.41% in 2022, then plummeted by -64bps to 0.68% in 2023, then dropped by -4bps to 0.7% in 2024, then surged by 81bps to 0.13% in 2025.
  • Per Business Quant, the three most recent readings for IPSC's Return on Equity are 0.13% (Q3 2025), 0.1% (Q2 2025), and 0.1% (Q1 2025).